DayStar Technologies, Inc. (DSTI) Issues Letter Entitled

New Post Public Reply Private Reply Replies (0) Message Board
testuser
DayStar Technologies, Inc. (DSTI) Issues Letter Entitled "DayStar a Year in Review"

KELOWNA, BC--(Marketwired - Apr 11, 2013) - DayStar Technologies, Inc. ( NASDAQ : DSTI ) issues the following letter regarding a corporate overview:

"DayStar a year in review:

DSTI, DayStar as of April 12, 2013 will become an OTC security. Over the past twelve months, several letters of intents were announced. However, closing some of those deals has been hindered due to lack of financing. Despite such challenges, the company has gone through a significant restructuring process that has left the company in its strongest position in the past five years.

Restructuring of DayStar includes many changes in key management positions. In March, 2013 Lorne Roseborough was appointed as a CEO of the company. Roseborough was a former board member and president of EPOD International, Inc. He also served as a Vice-President for Belkorp Industries, Inc. Under Roseborough, the company has managed to significantly reduce overheads from manufacturing assets, and the company is now in a position that it should be cash flow positive this year for the first time. DayStar continues the process of long-term debt reduction from $16 million to $1.5 million. The company also elected to sell inventory and technology rights to its CIGS tech in return Daystar has received common equity and senior secured equity in the acquirer.

In addition, over the last year DayStar was able to close the purchase of six fully completed projects in Hawaii. DayStar has also been able to identify multiple additional projects in Hawaii and is working persistently to close these projects.

DayStar has also entered into a definitive agreement to acquire 6 special purpose Companies that contain fully paid Solar equipment used to build Solar power generating Parks upon completion this will allow DayStar to build projects that could potentially generate $28 million in revenues. These Companies qualify for government cash grant under section 1603 of The American Recovery and Reinvestment Act of 2009, which will qualify facility owners for a one time grant equal to 30 percent of the construction and installation costs for the facility.

DayStar also has a $148 million tax loss carryover. If a company was interested in acquiring DayStar, DayStar would be conservatively estimated value from of this at 2% - 7% of the tax carryover subject to IRS and government approval.

One of the bigger potentials of DayStar is its relationship with the Breakfast Club of Canada. The founder of the Breakfast Club, Daniel Germain, serves DayStar as a member of Board of Directors. DayStar's relationship with the Club is expected to be a major cornerstone that will allow Daystar to build projects on establishments that are sponsored by the Club such as schools. The Breakfast Club has corporate partners that are Fortune 100 companies that could potentially work with DayStar.

Moreover, DayStar has secured the rights to acquire a 20% stake in a company that has sole rights to internationally patented and patent-pending technology that simultaneously stores and converts sunlight to electric power in a bio-solar cell this cell has significant groundbreaking efficiency. This technology should revolutionize solar industry and be a game changer in the energy industry.

Management at DayStar Technologies, Inc. appreciates the shareholders support, and the DSTI team is dedicated to make DayStar a successful solar energy company and produce shareholder value now and in the future.

With warmest regards,

Management DayStar Technologies, Inc."

About DayStar Technologies Inc . DayStar Technologies, Inc. (DSTI) is a developer of solar photovoltaic products and has assembled a world-class team of project engineers, and industry finance professionals, to facilitate the complete development of renewable energy projects throughout the world. DayStar is currently embarking on a strategy of strategic partnerships to enter new markets within the global renewal energy industry including ownership and construction of solar and renewable power plants. For more information, visit the DayStar website at http://www.daystartech.com/ .

For corporate information, contact Mr. Dan Giesbrecht, VP Business Development, info@daystartechinc.com , 778-484-5159.

For Investor Relations, contact Mr. William Nalley, Orsay Groupe, info@orsaygroupe.com , phone 305-515-8077.

Safe Harbor :

Statements contained in news release, which are not historical facts, may be forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like "believe," "expect," "anticipate," "estimate" and "intend" or future or conditional verbs such as "will," "would," "should," "could" or "may." We undertake no obligation to update any forward-looking statements.

Contact: Dan Giesbrecht VP Business Devlopment DayStar Technologies Email Contact 778-484-5159 Mr. William Nalley Orsay Groupe Email Contact 305-515-8077

Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Radiation Oncology Text Earns Doody's 2026 Nod

Updated Category News Views 24

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Continue Reading
Curis Prepares for Q3 2026 Results Amid Tough Sector Trends

Updated Category News Views 139

All Eyes on Curis as Q3 Financials Loom Just when you think you’ve seen it all in this wild biotech ride, Curis, Inc. (NASDAQ: CRIS) is prepping to roll out their third quarter financial and operating results. Circle your calendars for November 12, 2026, because the clock’s ticking down to their 4:00 p.m. ET announcement, swiftly followed by a conference call at 4:30...

Continue Reading
Home Insurance Depreciation and What it Means for You

Updated Category News Views 17

A Deep Dive into Depreciation's Impact on Home Insurance Folks, if you haven't battled the insurance beast, you're missing out on an unholy mess. Let's talk about something that's been quietly gnawing at homeowners’ wallets—depreciation in home insurance claims. Peggy Schneider, an insurance guru from Kalispell, Montana, lays it all out in HelloNation, and I'm here to...

Continue Reading
FDA Greenlights Halozyme's Cancer Treatment Breakthrough

Updated Category News Views 18

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Continue Reading
Birth Registration Revolution: OSIA Interoperability Demo

Updated Category News Views 86

Bringing Birth Registration into the 21st Century Alright, let's cut through the fog. If you ask most folks about their birth certificates, you'd hear tales of tattered paper and government office runs. What if I told you this vital piece of paper could be reborn altogether? That's what the Secure Identity Alliance is up to with their OSIA Live Interoperability Demo at...

Continue Reading
TELUS Boosts Board with Strategic Executive Appointments

Updated Category News Views 47

New Faces on the TELUS Board: Shaping the Future Alright, investors, here's the scoop straight from the trenches: TELUS (TSX:TU) is shaking things up at the top. Marc Allera and Bill Thomas are stepping into the fray as the newest members of the board, effective January 1, 2027. If you're not familiar with these names, it's time to tune in because they've got the chops to...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 68

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Bowling Makes a Strike at Macy's 100th Parade in NYC

Updated Category News Views 64

Rolling with Tradition: Bowling at Macy's Parade Back in the day, bowling wasn't exactly the sport making headlines. But times, they change. Here we are in the thick of things, witnessing Go Bowling getting its moment in the spotlight during the historic 100th Macy's Thanksgiving Day Parade®. It's not about raking in the dough or hitting some stocks; it’s about...

Continue Reading
PPL Reports Strong Q3; Long-Term EPS Growth Up

Updated Category News Views 29

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Continue Reading
Tucows Shows Progress in Q3 2026 Amidst Net Loss

Updated Category News Views 140

Q3 Snapshot: Balancing Act at Tucows Man, if there's one thing you can count on from Tucows, it's that they'll shuffle the deck just when you're getting comfortable. Here in the third quarter of 2026, they've managed a decent juggling act. Their unaudited numbers show consolidated net revenue ticking up 1.4% from last year, rounding out at a cool $100 million. That's...

Continue Reading

Top 5 Most Recently Viewed Articles

Nicole Kidman's New Role as Clé de Peau Beauté Ambassador

Updated Category News Views 302

Nicole Kidman Joins Clé de Peau Beauté as Global Brand Ambassador The renowned and celebrated Hollywood actress, Nicole Kidman, has taken on a monumental role as the new Global Brand Ambassador for Clé de Peau Beauté, a brand recognized for its luxurious skincare and makeup offerings. Kidman's exceptional presence in the entertainment industry transcends mere stardom;...

Continue Reading
Future FinTech Group Unveils Innovative AI Trading Platform

Updated Category News Views 171

Future FinTech Group Launches AI-Powered Trading Platform Future FinTech Group Inc. (NASDAQ: FTFT), known for its comprehensive financial and digital technology services, has initiated an exciting endeavor with its subsidiary, FTFT International Securities & Futures Co., Ltd. ("Future Securities"). This strategic move aims to revolutionize investment analytics and trading...

Continue Reading
GardaWorld Finalizes Successful Credit Facility Enhancements

Updated Category News Views 124

GardaWorld's Strategic Credit Facility Enhancements MONTREAL / -- Garda World Security Corporation, known as GardaWorld, is making significant strides in its operational efficiency and financial management. This entrepreneurial-driven company specializes in security services and innovative risk solutions. Recently, GardaWorld has successfully completed amendments to its...

Continue Reading
Transformative Trends in eCommerce: The Future of Marketing

Updated Category News Views 361

Understanding the Future of eCommerce Marketing As we approach a pivotal moment in the eCommerce realm, it's essential to recognize the trends that are not only shaping the industry today but are also setting the stage for 2025. The digital marketplace is evolving rapidly, and organizations must adapt to thrive. Based on insights shared by leading experts, including CEO...

Continue Reading
OSE Immunotherapeutics Reveals Strategic Innovations for Growth

Updated Category News Views 238

OSE Immunotherapeutics Shapes Future with 2026-2028 Strategic Vision OSE Immunotherapeutics has unveiled an ambitious strategic plan aimed at enhancing its product offerings and maximizing shareholder value. This plan is designed for the upcoming three years and spans innovative treatments and strategic initiatives that promise to propel the company forward in the...

Continue Reading